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Attenuation of influenza viruses for the development of live vaccines can be
accomplished by transferring attenuated genes from an attenuated donor virus to the
new epidemic or pandemic strain by genetic reassortment (4). One donor virus, an
influenza A/Ann Arbor/6/60 cold-adapted variant, was produced by serial passage
in primary chick kidney (PCK) cells by gradually lowering the incubation tempe-
rature to 25 C which restricts the growth of wild type influenza viruses (1). During
adaptation at the lower temperature, the A/Ann Arbor/6/60 virus acquired two
phenotypic mutations, a cold-adapted (ca) property and a temperature-sensitive (ts)
property at a shutoff temperature of 37-38 C (10). In studies of reassortant viruses
derived from the A/Ann Arbor/6/60 donor strain, reassortants possessing the ca and
ts properties lost their virulence for animals and humans (2, 3). However, A/Ann
Arbor/6/60 donor virus genes which confer both the ca and ts properties and attenua-
tion have not been unequivocally identified since most of the reassortants available
for examination have multiple genes from the A/Ann Arbor/6/60 virus and possess
both ca and ts properties as a linked phenotype.
Recently, we isolated some limited gene reassortants of A/Ann Arbor/6/60 X
A/Alaska/6/77 viruses and demostrated that the ca property can be segregated from
the ts property at either 25 or 33 C, which is a permissive temperature for growth of
influenza virus (7). Correlations between the reassortants' gene constellations and
their phenotypic markers, ca and ts, were also assessed.
The present study explores the functions of both the ca and ts properties in the
ca reassortants with respect to their virulence or attenuation in mice.
Influenza A viruses used in this study were the A/Ann Arbor/6/60 (H2N2) ca
variant as an attenuated donor strain for mice, the A/Alaska/6/77 (H3N2) wild type,
and four ca reassortant viruses. The reassortants were produced in Madin-Darby
canine kidney (MDCK) cells by mixed infection with the A/Ann Arbor/6/60 ca donor
and the A/Alaska/6/77 viruses at either 25 or 33 C (7).
Table 1 presents a summary of the gene constellations of the ca reassortants and
their biological phenotypes as expressed in MDCK cells. Two (T66-1-1 and T 66-2-1)
of the four reassortants exhibited ca and ts phenotypes while the others (T325-1-l
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and T431-1-1) exhibited ca and non ts phenotypes. Four-week-old CD (ICR)
mice obtained from Charles River Breeding Laboratories, Inc. were used as a
laboratory model to assess virulence of the reassortants based on their viral
Table I. Gene constellations and biological properties of ca reassortant viruses
RNA segments
Clone (Polymerase) Biologicals:(HA) (NA) (NP) (MP) (NS) phenotype
2 3 4 5 6 7 8
T325-I-l wtb ) AAC) wt wt AA wt wt wt ca and non-ts
T 431-I-l wt AA wt wt wt wt wt wt ca and non-ts
T 66-1-1 wt AA AA wt AA wt wt wt ca and ts
T 66-2-l wt AA AA wt AA wt wt wt ca and ts
0) ca indicates substantial growth at 25 C; ts indicates little or no growth at 39 C,
non-ts indicates substantial growth at 39 C.
b) wt, RNA derived from AjAlaskaj6j77 (H3N277) wild type virus.
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Fig. I. Growth patterns of ca reassortant viruses and their parental strains in mice.
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replicative ability in the lungs and nasal turbinates. The virus dilutions were
prepared in a nutrient broth containing penicillin (200 fJg/ml) and streptomycin
(4 fJg/ml) with a dose of 5.0 X 105 PFU/ml at a volume of 5 ml and administered by
aerosol exposure for 30 min. Groups of three mice each were sacrificed by cervical
dislocation on days 1, 2, 4, 6, and 8 after infection and the lungs and turbinates were
removed. The lungs and turbinates were pooled separately, and 10% weight/
volume tissue homogenates were prepared as described previously (11). The viral
content of the tissue homogenates was evaluated by inoculation into lO-day-old eggs,
and incubated for 72 hr at 33 C. The titer, expressed as 50% egg infectious dose
(EID50/ml), was calculated by the method of Reed and Muench (8).
Figure 1 shows the virus growth patterns of ca reassortant clones and their
parental strains in mouse lungs and turbinates. The wild type A/Alaska/6/77 virus
began to replicate in the lungs and turbinates from day 1 after infection. No signifi-
cant differences were found in the titers of the virus recovered from the lungs (maxi-
mum titer: 7.210g10 EID50/ml) and the turbinates (6.710glO EID5o/ml). Replication
of the A/Ann Arbor/6/60 donor strain was completely restricted in the lungs. The
donor strain grew only in the turbinates and a significant titer was observed 6 days
after infection, but the maximum titer was lO-fold less than that of A/Alaska/6/77
wild type strain (top panel). Clones T 66-1-1 and T66-2-1, which possess the ca and
ts properties, replicated in the turbinates with maximum titers of 4.8 10gloEID5oj
ml and 2.7 10glOEID50/ml, respectively. The growth of these clones in the lungs
was also completely restricted (middle panel). On the other hand, two reassor-
tants T325-1-1 and T 431-1-1, which possess only the ca property, replicated in both
the lungs and turbinates with maximum titers comparable to that of A/Alaska/6/
77 wild type virus (bottom panel). These results, therefore, indicate that replica-
tion of the ca reassortants in the lungs is affected by the acquisition of the ts prop-
erty from the AjAnn Arbor/6/60 donor virus.
Studiesofts reassortant viruses derived from A/Udorn/72-ts-lA2 donor virus pre-
viously demonstrated that the ts genes of the donor virus are responsible for attenua-
tion in humans (6) and that the shutoff temperatures of plaque formation in vitro is
related to the level of the viral replication in the lungs of hamsters (5). The function
of the ts property in attenuation of the A/Ann Arbor/6/60 donor virus is still obscure,
however, since the ca reassortants bearing different shutoff temperatures do not
show a significant variation in their level of attenuation for humans (9). Although
no ca reassortant virus possessing non ca and ts phenotypes has been isolated yet, our
present data suggest that the ts property of A/Ann Arbor/6/60 virus is essential in
attenuating ca reassortant viruses.
The role of the ca property plays in attenuation of the A/Ann Arbor/6j60 donor
virus is also unclear. Two ca and non ts reassortants replicated well in mouse lungs,
however, the duration ofviral growth was significantly shorter than that of A/Alaska/
6/77 wild type virus (Fig. 1 top and bottom panels). A "single gene" reassortant
(T431-1-1) bearing only RNA 2 from the A/Ann Arbor/6j60 virus with all remaining
genes from the wild type virus (Table 1) showed significant titers in the lungs for 4
days. T 325-1-1 is a "double gene" reassortant bearing both RNA 2 and neuramini-
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dase genes which function individually to express the ca phenotype in MDCK cells
and the virus grew for 2 days only. These results strikingly reveal that the shortened
viral replication time in mouse lungs is related to the increasing number of ca genes
transferred from the A/Ann Arbor/6/60 virus to the ca reassortants.
Recently we obtained similar results in a study using ferrets (submitted for
publication). Thus, these findings imply that the ca property of the A/Ann
Arbor/6/60 donor virus plays a secondary or supporting role to the ts property in
alteration of virulence of the ca reassortant viruses.
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